[1]
Erturk, I., Ozgurtas, T., Elasan, S., Acar, R., Buyukturan, G., Aydin, F.N., Yildiz, B., Yesildal, F. and Saglam, K. 2018. Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin. International Journal of Medical Science and Clinical invention. 5, 11 (Nov. 2018), 4157-4161. DOI:https://doi.org/10.18535/ijmsci/v5i11.04.